Over the last decade, the number of children diagnosed with bipolar disorder has increased up to fortyfold. This is a trend exclusive to the United States, and one that, alarmingly, leads to most of the diagnosed children—some still in their infancy—being prescribed antipsychotic drugs, often in combination with anticonvulsants. These classes of drugs have dangerous side effects, including a doubling of mortality rates, shortened life span, extreme weight gain, and Type II diabetes. In this book, psychologist Sharna Olfman leads a team of widely known experts who examine that astonishing rise in the diagnosis of pediatric bipolar disorder, particularly in the absence of any compelling evidence for either the validity of the criteria being used to diagnose it or the safety and effectiveness of the drugs being used to treat it. When a child is unnecessarily prescribed antipsychotic and anticonvulsant drugs, his or her mental and physical health may be irrecoverably compromised, says Olfman. With as many as two-and-a-half million children from across the socioeconomic spectrum now taking antipsychotics, we have set the stage for widescale child abuse. The contributors to this revealing and disturbing volume include psychiatrist David Healy, one of the world's leading authorities on psychotropic drugs; pediatrician Philip Landrigan, an internationally renowned health researcher; and Robert Whitaker, an award winning medical journalist. The contributors identify and explain complex and interrelated factors that have set the stage for the pediatric bipolar epidemic, and they recommend practice and policy changes to stem the tide of misdiagnosis and dangerous drug prescriptions.
This book exposes the skyrocketing rate of antipsychotic drug prescriptions for children, identifies grave dangers when children's mental health care is driven by market forces, describes effective therapeutic care for children typically prescribed antipsychotics, and explains how to navigate a drug-fueled mental health system. Since 2001, there has been a dramatic increase in the use of antipsychotics to treat children for an ever-expanding list of symptoms. The prescription rate for toddlers, preschoolers, and middle-class children has doubled, while the prescribing rate for low-income children covered by Medicaid has quadrupled. In a majority of cases, these drugs are neither FDA-approved nor justified by research for the children's conditions. This book examines the reasons behind the explosion of antipsychotic drug prescriptions for children, spotlighting the historical and cultural factors as well as the role of the pharmaceutical industry in this trend; and discusses the ethical and legal responsibilities and ramifications for non-MDs—psychologists in particular—who work with children treated with antipsychotics. Contributors explain how the pharmaceutical industry has inserted itself into every step of medical education, rendering objectivity in the scientific understanding, use, and approvals of such drugs impossible. The text describes the relentless marketing behind the drug sales, even going as far as to provide coloring and picture books for children related to the drug at issue. Valuable information about legal recourse that families and therapists can take when their children or patients have been harmed by antipsychotic drugs and alternative approaches to working with children with emotional and behavioral challenges is also provided.
Over the last decade, the number of children diagnosed with bipolar disorder has increased up to fortyfold. This is a trend exclusive to the United States, and one that, alarmingly, leads to most of the diagnosed children—some still in their infancy—being prescribed antipsychotic drugs, often in combination with anticonvulsants. These classes of drugs have dangerous side effects, including a doubling of mortality rates, shortened life span, extreme weight gain, and Type II diabetes. In this book, psychologist Sharna Olfman leads a team of widely known experts who examine that astonishing rise in the diagnosis of pediatric bipolar disorder, particularly in the absence of any compelling evidence for either the validity of the criteria being used to diagnose it or the safety and effectiveness of the drugs being used to treat it. When a child is unnecessarily prescribed antipsychotic and anticonvulsant drugs, his or her mental and physical health may be irrecoverably compromised, says Olfman. With as many as two-and-a-half million children from across the socioeconomic spectrum now taking antipsychotics, we have set the stage for widescale child abuse. The contributors to this revealing and disturbing volume include psychiatrist David Healy, one of the world's leading authorities on psychotropic drugs; pediatrician Philip Landrigan, an internationally renowned health researcher; and Robert Whitaker, an award winning medical journalist. The contributors identify and explain complex and interrelated factors that have set the stage for the pediatric bipolar epidemic, and they recommend practice and policy changes to stem the tide of misdiagnosis and dangerous drug prescriptions.
A stellar group of authors from across disciplines explains the alarming increase in the use of psychotropic medications, questions the causes, and presents disturbing thoughts regarding this phenomenon and the risks it creates for children. They take an in-depth look at the conditions that have led to drugging our children, and stress how emotional, social, cultural, and physical environments can both damage and heal young minds. And they challenge the model that maintains that psychological disturbance is genetic and thus requires medication. This is riveting reading for all who care about the youngest members of society. Over the past 15 years, there has been a 300 percent increase in the use of psychotropic medications with girls and boys under the age of 20, and prescriptions for preschoolers have skyrocketed. A stellar group of authors from across disciplines explains this increase, questions the causes, and presents disturbing thoughts regarding this phenomenon as they describe the risks it creates for children. While there are certainly extreme cases where drugs are the only option, medication rather than psychotherapy and counseling has become the first choice for treatment rather than a last resort. The experts who joined forces for this book take an in-depth look at the conditions that have led to drugging our children, and stress how emotional, social, cultural, and physical environments can both damage and heal young minds. The so-called medical model, one maintaining that psychological disturbance is genetic and thus requires medication, is challenged in this volume. Contributors range from a pediatrician who has testified before Congress and been featured in a Time magazine cover story, to a top child psychiatrist who is an official for the American Academy of Child and Adolescent Psychiatry, along with a well-known child psychiatrist, psychologists, environmentalists, and a public policy consultant. This is riveting reading for all who care about the youngest members of society. Among other issues, this work looks at controversy over whether psychiatric medications are safe or effective for children—and what little we know about their effect on still-developing brains—as well as the role of corporate interests in the increased use of psychotropics for children. Chapters address the role of environment in both causing and curing disorders more and more often diagnosed in our youngsters: from ADHD, depression, and anxiety to eating disorders. The core questions addressed by this sage group of contributors are these: Why are so many children being diagnosed with psychiatric disturbances and given drugs? Why have drugs become the first treatment of choice to deal with those disorders?
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.